News & Updates

Show Multimedia Only
Probiotic supplementation in pregnant women with obesity of little benefit to mothers, babies
Probiotic supplementation in pregnant women with obesity of little benefit to mothers, babies
05 Aug 2023

In pregnant women with obesity, supplementation with multi-strain probiotics does not appear to have favourable effects on the metabolic or inflammatory biomarkers in mothers and on the body composition of their offspring, according to a study.

Probiotic supplementation in pregnant women with obesity of little benefit to mothers, babies
05 Aug 2023
Synbiotics help reduce weight in adults with overweight, obesity
Synbiotics help reduce weight in adults with overweight, obesity
03 Aug 2023

Synbiotics V5 and V7 effectively reduce body weight in individuals with obesity or overweight undergoing lifestyle modification, as shown in a study.

Synbiotics help reduce weight in adults with overweight, obesity
03 Aug 2023
Endometriosis not a risk factor for type 2 diabetes
Endometriosis not a risk factor for type 2 diabetes
02 Aug 2023

The presence of endometriosis does not appear to contribute to an increased risk of type 2 diabetes in women, according to a study.

Endometriosis not a risk factor for type 2 diabetes
02 Aug 2023
Diabetes mellitus is a growing health problem traditionally characterized by peripheral insulin resistance (IR), increased he
Diabetes mellitus is a growing health problem traditionally characterized by peripheral insulin resistance (IR), increased hepatic gluconeogenesis, and impaired pancreatic beta-cell function. However, the pathophysiology of T2DM is complex, and disease progression is linked to factors beyond insulin dysregulation and reduced first-phase insulin response.
02 Aug 2023 byJoanne G. Blanco, MD

Diabetes mellitus is a growing health problem traditionally characterized by peripheral insulin resistance (IR), increased hepatic gluconeogenesis, and impaired pancreatic beta-cell function.1 However, the pathophysiology of T2DM is complex, and disease progression is linked to factors beyond insulin dysregulation and reduced first-phase insulin response.2 Unfortunately, many existing anti-hyperglycemic medications cause side effects such as hypoglycemia and weight gain, which may reduce adherence to treatment. In contrast, ideal diabetes medications would control glycemia without a risk of hypoglycemia, while providing additional beneficial effects on beta-cell function, body weight, lipid profiles, hypertension and cardiovascular risk.3

Diabetes mellitus is a growing health problem traditionally characterized by peripheral insulin resistance (IR), increased hepatic gluconeogenesis, and impaired pancreatic beta-cell function. However, the pathophysiology of T2DM is complex, and disease progression is linked to factors beyond insulin dysregulation and reduced first-phase insulin response.
02 Aug 2023
Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women
Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women
26 Jul 2023

For postmenopausal women with a history of gestational diabetes, delivering high birth weight infants or hypertensive disorders of pregnancy poses a heightened risk of developing type 2 diabetes (T2D) in the future, according to a study.

Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women
26 Jul 2023
Boys with T1DM now hit puberty early
Boys with T1DM now hit puberty early
24 Jul 2023

For a significant number of boys with type 1 diabetes mellitus (T1DM), puberty may start early than it used to, as reported in a study for Greece.

Boys with T1DM now hit puberty early
24 Jul 2023